CapeRay Medical
| CapeRay logo | |
| Private | |
| ISIN | 🆔 |
| Industry | Medical products |
| Founded 📆 | 2010 |
| Founder 👔 | |
| Headquarters 🏙️ | Cape Town, South Africa |
Area served 🗺️ | |
Key people | Christopher L. ‘Kit’ Vaughan Founder and CEO |
| Products 📟 | Digital mammography |
| Members | |
Number of employees | |
| 🌐 Website | http://www.caperay.com |
| 📇 Address | |
| 📞 telephone | |
CapeRay Medical (Pty) Ltd is a privately held company based in Cape Town, South Africa, that develops, manufactures, and supplies medical imaging equipment for the diagnosis of breast cancer.[1] The company traces its roots to African Medical Imaging (AMI), a joint venture between De Beers and the University of Cape Town (UCT), that was established in 1999.[2]
History[edit]
Funding for the company came first from the Innovation Fund of South Africa in 2009[2], which is now part of the Technology Innovation Agency, followed by a grant from the National Institutes of Health in the USA, and finally an investment by the venture capital arm of the Industrial Development Corporation of South Africa. Kit Vaughan is founder and CEO, having facilitated the formation of CapeRay as a spin out company.
Breast Cancer Imaging Technology[edit]
CapeRay's main focus, medical imaging equipment for breast cancer, evolved from a combination of both X-ray imaging and that of ultrasound.[3] The company first began with the PantoScanner platform, building two devices using it; the preliminary Soteria, and the later Aceso, and holds two patents relating to the imaging techniques thereof.[4] The company plans to later apply the patents to a future device, Aegle, which will integrate automated breast ultrasound with digital breast tomosynthesis.[5]
Aceso[edit]
CapeRay's primary product, Aceso (named after the Greek goddess of healing[6]), was developed in several generations, with the latest version of the instrument successfully undergoing clinical trials and showing high resolution beyond the benchmarks of the European Reference.[7] In 2015, Aceso began testing at the Groote Schuur Hospital, building upon the device's ISO certification to undergo practical testing after efficiency in clinical trials.[8] Aceso resulted in the company being a finalist for the Innovation Prize for Africa, run by the African Innovation Fund.[9]
References[edit]
- ↑ Forshaw, Joe (May 2017). "On the Cusp of a Breast Cancer Breakthrough". Enterprise Africa. pp. 8–15.
- ↑ 2.0 2.1 Jarvis, Emily. "A Revolution in Breast Imaging". Africa Outlook. Retrieved 27 June 2018.
- ↑ Marsh, Brenda (June 2012). "X-ray and ultrasound combo on a mammo platform". European Hospital. 21: 16.
- ↑ "Patents Assigned to CAPERAY MEDICAL (PTY) LTD". Justia Patents. Retrieved 27 June 2018.
- ↑ Martins, Ines (12 May 2017). "CapeRay Wins US Patent for Dual-Mode Imaging System to Detect Breast Cancer". Breast Cancer News. Retrieved 27 June 2018.
- ↑ Vaughan, Christopher L.; et al. (June 2016). "Testing a dual-modality system that combines full-field digital mammography and automated breast ultrasound". Clinical Imaging. 40 (3): 498–505. doi:10.1016/j.clinimag.2015.11.024.
- ↑ Padia, Kamila; et al. (18 March 2017). "Detecting Breast Cancer with a Dual-Modality Device". Diagnostics. 7 (1): 17. doi:10.3390/diagnostics7010017.
- ↑ Sanchez, Dana (11 November 2015). "South Africa Claims Breakthrough In Breast Cancer Diagnosis Tech". Moguldom. Retrieved 27 June 2018.
- ↑ Moyo, Admire (10 May 2016). "SA's breakthrough medical tech makes African cut". IT Web. Retrieved 27 June 2018.
External links[edit]
This article "CapeRay" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:CapeRay. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
